Publications (37) Daniel Apolinar García Estévez publications

2023

  1. Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

    Multiple Sclerosis and Related Disorders, Vol. 75

  2. Clinical features of mitochrondrial diseases: A retrospective study in adult patients with muscle symptoms

    Journal of the Neurological Sciences, Vol. 455, pp. 121688

  3. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  4. Epidemiology of myasthenia gravis in the province of Ourense (Galicia, Spain)

    Neurologia, Vol. 38, Núm. 2, pp. 75-81

  5. Epidemiología de la miastenia grave en la península ibérica y Latinoamérica

    Revista de neurologia, Vol. 76, Núm. 2, pp. 59-68

  6. Hyperbaric oxygen therapy in long-COVID-19 disease

    Medicina Clinica

  7. Myasthenia gravis. Update on diagnosis and therapy

    Medicina Clinica, Vol. 161, Núm. 3, pp. 119-127

  8. Prevalencia de la miastenia grave en Colombia. Réplica

    Revista de neurologia

2022

  1. Analysis of medication persistence and reasons for discontinuation of treatment with teriflunomide and dimethyl fumarate in a hospital series of patients with multiple sclerosis

    Neurology Perspectives, Vol. 2, Núm. 3, pp. 168-170

  2. Clinical and radiological effectiveness of natalizumab extended dosage interval in patients with relapsing multiple sclerosis

    Revista de Neurologia, Vol. 74, Núm. 3, pp. 265-268

  3. Hereditary spastic paraplegia type 4: Description of a family with a new pathogenic SPAST gene variant, c.1156A > C (p.Asn386His)

    Neurology Perspectives, Vol. 2, Núm. 1, pp. 53-55

2021

  1. 25(Oh)D3 deficit and multiple sclerosis: A simple epidemiological association or a true causal relationship

    Neurologia

  2. Benign multiple sclerosis, old age, and cognitive impairment: Is teriflunomide an appropriate treatment for this clinical triad?

    Neurology Perspectives, Vol. 1, Núm. 3, pp. 189-191

  3. Cognitive impairment in relapsing-remitting multiple sclerosis: a clinical practice study using the Symbol Digit Modalities Test and conventional magnetic resonance imaging

    Neurology Perspectives, Vol. 1, Núm. 1, pp. 27-32

2020

  1. Prevalencia de la esclerosis múltiple en la ciudad de Ourense, Galicia, noroeste de la Península Ibérica

    Revista de neurologia, Vol. 71, Núm. 1, pp. 19-25

2018

  1. Isolated dysarthria and dysphagia as the presenting symptoms of simultaneous bilateral acute lacunar ischemic stroke

    Revista de Neurologia

  2. Proceso asistencial integrado de esclerosis lateral amiotrófica

    Conselleria de Sanidade

2017

  1. Cefalea trigeminoautonómica secundaria a un hematoma intraorbitario Espontáneo

    Revista de Neurologia

  2. Hemorragia subaracnoidea espontánea de la convexidad cerebral: una serie clínica de 3 pacientes asociada con angiopatía amiloide cerebral

    Neurologia, Vol. 32, Núm. 4, pp. 213-218

2016

  1. Fingolimod: Efectividad y seguridad en la práctica clínica habitual. Estudio observacional,retrospectivo y multicéntrico en Galicia

    Revista de Neurologia, Vol. 63, pp. S13-S18